 |
The Journal of Neuroscience, February 25, 2004, 24(8):1881-1887; doi:10.1523/JNEUROSCI.4407-03.2004
Previous Article | Next Article 
Neurobiology of Disease
Disease Progression Despite Early Loss of Polyglutamine Protein Expression in SCA7 Mouse Model
Dominique Helmlinger,1
Gretta Abou-Sleymane,1
Gaël Yvert,1
Stéphane Rousseau,2
Chantal Weber,1
Yvon Trottier,1
Jean-Louis Mandel,1 and
Didier Devys1
1Department of Molecular Pathology, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique-Institut National de la Santé et de la Recherche Médicale-Université Louis Pasteur, and 2Mouse Clinical Institute, 67404 Illkirch, France
Nine neurodegenerative diseases including Huntington's disease (HD) and spinocerebellar ataxia type 7 (SCA7) are caused by an expansion of a polyglutamine (polyQ) stretch in the respective proteins. Aggregation of expanded polyQ-containing proteins into the nucleus is a hallmark of these diseases. Recent evidence indicates that transcriptional dysregulation may contribute to the molecular pathogenesis of these diseases. Using SCA7 and HD mouse models in which we recently described a retinal phenotype, we investigated whether altered gene expression underlies photoreceptor dysfunction. In both models, rhodopsin promoter activity was early and dramatically repressed, suggesting that downregulation of photoreceptor-specific genes plays a major role in polyQ-induced retinal dysfunction. Because the rhodopsin promoter drives mutant ataxin-7 expression in our SCA7 mice, we also assessed whether downregulation of mutant SCA7 transgene would reverse retinopathy progression and aggregate formation. Although residual expression of mutant ataxin-7 was found negligible from 9 weeks of age, SCA7 transgenic mice showed a progressive decline of photoreceptor activity leading to a complete loss of electroretinographic responses from 1 year of age. At this age, aggregates were cleared in only half of the photoreceptors, indicating that their formation is not fully reversible in this model. We demonstrate here that abolishing full-length mutant ataxin-7 expression did not reverse retinopathy progression in SCA7 mice, raising the possibility that some polyQ-induced pathological events might be irreversible.
Key words: neurodegeneration; polyglutamine; retina; transcriptional alteration; reversibility; aggregates
Received Sep 29, 2003;
revised November 20, 2003;
accepted December 19, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
P. Pascual-Garcia, C. K. Govind, E. Queralt, B. Cuenca-Bono, A. Llopis, S. Chavez, A. G. Hinnebusch, and S. Rodriguez-Navarro
Sus1 is recruited to coding regions and functions during transcription elongation in association with SAGA and TREX2
Genes & Dev.,
October 15, 2008;
22(20):
2811 - 2822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen and J. Nathans
Genetic Ablation of Cone Photoreceptors Eliminates Retinal Folds in the Retinal Degeneration 7 (rd7) Mouse
Invest. Ophthalmol. Vis. Sci.,
June 1, 2007;
48(6):
2799 - 2805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Latouche, C. Lasbleiz, E. Martin, V. Monnier, T. Debeir, A. Mouatt-Prigent, M.-P. Muriel, L. Morel, M. Ruberg, A. Brice, et al.
A Conditional Pan-Neuronal Drosophila Model of Spinocerebellar Ataxia 7 with a Reversible Adult Phenotype Suitable for Identifying Modifier Genes
J. Neurosci.,
March 7, 2007;
27(10):
2483 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Jacobson, A. V. Cideciyan, T. S. Aleman, A. Sumaroka, S. B. Schwartz, E. A. M. Windsor, A. J. Roman, E. Heon, E. M. Stone, and D. A. Thompson
RDH12 and RPE65, Visual Cycle Genes Causing Leber Congenital Amaurosis, Differ in Disease Expression
Invest. Ophthalmol. Vis. Sci.,
January 1, 2007;
48(1):
332 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Janer, E. Martin, M.-P. Muriel, M. Latouche, H. Fujigasaki, M. Ruberg, A. Brice, Y. Trottier, and A. Sittler
PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins
J. Cell Biol.,
July 3, 2006;
174(1):
65 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Abou-Sleymane, F. Chalmel, D. Helmlinger, A. Lardenois, C. Thibault, C. Weber, K. Merienne, J.-L. Mandel, O. Poch, D. Devys, et al.
Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program
Hum. Mol. Genet.,
March 1, 2006;
15(5):
691 - 703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iijima-Ando, P. Wu, E. A. Drier, K. Iijima, and J. C. P. Yin
cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila
PNAS,
July 19, 2005;
102(29):
10261 - 10266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Helmlinger, J. Bonnet, J.-L. Mandel, Y. Trottier, and D. Devys
Hsp70 and Hsp40 Chaperones Do Not Modulate Retinal Phenotype in SCA7 Mice
J. Biol. Chem.,
December 31, 2004;
279(53):
55969 - 55977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Everett and N. W. Wood
Trinucleotide repeats and neurodegenerative disease
Brain,
November 1, 2004;
127(11):
2385 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Helmlinger, S. Hardy, S. Sasorith, F. Klein, F. Robert, C. Weber, L. Miguet, N. Potier, A. Van-Dorsselaer, J.-M. Wurtz, et al.
Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes
Hum. Mol. Genet.,
June 15, 2004;
13(12):
1257 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|